Discontinued — last reported Q4 '24
Products & Services · Net Sales
Other — Net Sales
Over 3 years (FY 2021 to FY 2024), Other — Net Sales shows a downward trend with a -100.0% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ4 2024
Rolls up toTotal Revenue
How to read this metric
An increase suggests the company is successfully monetizing non-core assets or secondary business lines, while a decrease may indicate a strategic divestiture or the winding down of legacy operations.
Detailed definition
This metric represents the total revenue generated from business activities, product lines, or service offerings that do...
Peer comparison
Peers often report similar figures under 'Other', 'Corporate', or 'Unallocated' segments, though the composition of these segments varies significantly based on the company's specific portfolio structure.
Metric ID:
bsx_segment_other_net_salesHistorical Data
4 years
| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $13.00M | -$60.00M | $0.00 | $0.00 |
| YoY Change | — | -561.5% | +100.0% | — |
Range-$60.00M – $13.00M
CAGR-100.0%
Avg YoY Growth-230.8%
Median YoY Growth-230.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's other — net sales?
- Boston Scientific (BSX) reported other — net sales of $0.00 in Q4 2024.
- What is the long-term trend for Boston Scientific's other — net sales?
- Over 3 years (2021 to 2024), Boston Scientific's other — net sales has grown at a -100.0% compound annual growth rate (CAGR), from $13.00M to $0.00.
- What does other — net sales mean?
- Total revenue generated from business activities that are not classified within the company's main reporting segments.